Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0018099 (
gout
)
5,192
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Recent studies have confirmed that
gout
is an inborn error of metabolism. It has now become evident that the hyperuricemia associated with
gout
might occur either due to overproduction of uric acid, underexcretion of uric acid or a combination of these processes. Furthermore, patients with excessive purine synthesis may have a specific enzyme defect resulting in altered feedback inhibition of purine synthesis. A
neurological disease
manifest by mental retardation, choreo-athetosis, aggressive behavior, lip-biting and self-mutilation and associated with decidedly increased purine biosynthesis serves as a prototype of this kind of disorder. Other defects in regulation of purine biosynthesis have been postulated but their existence not yet confirmed. It has been demonstrated that urate crystals which are deposited from hyperuricemic body fluids set up an acute inflammatory reaction by means of a variety of chemical mediators. Thus, acute gouty arthritis is now recognized as an example of "crystal induced" synovitis. The treatment of
gout
consists of (1) the control of acute gouty attacks, and (2) the maintenance of normal serum uric acid concentrations. This latter may be achieved either with uricosuric drugs or with xanthine oxidase inhibition. With these principles in mind, it is now possible to avoid many of the severe crippling effects of
gout
and to restore the vast majority of gouty patients to useful and productive lives.
...
PMID:Current concepts of hyperuricemia and gout. 577 83
Retroviruses have been implicated as causative agents of a variety of human diseases including malignancy, immune system dysfunction, and
neurologic disorders
. Despite the isolation of various retroviral agents from patients suffering from malignant neoplasias and
neurologic disorders
, only the human T-cell lymphotropic virus type I (HTLV-I) and the human immunodeficiency virus (HIV) have been definitively accepted as etiologic agents of human disease (Hjelle, 1991; Gessain and
Gout
, 1992; Rosenblatt, 1993). Because of their increasingly defined roles in disease progression, the replication of HTLV-I and HIV is an important focus for understanding the pathogenic processes resulting from viral infection. Of particular interest are the molecular mechanisms by which expression of retroviral genomes is regulated by their regulatory units, the long terminal repeats (LTR), in a manner specific to the cellular targets which they infect.
...
PMID:Neuroglial-specific factors and the regulation of retrovirus transcription. 787 99
In the introductory part of this article the history/legend of coffee as well as its spread to different parts of the world including Europe is discussed. Data sofar available in literature do not give any convincing evidence regarding clear relationship between coffee and the etiopathogenesis of several diseases including diabetes mellitus type 2, cardiovascular diseases,
gout
, osteoporosis,
neurologic disorders
and colorectal cancer. Favorable (protective) effects of coffee consumption against hepatocellular cancer have been repeatedly described. The autors discuss on todate findings about relationship between blood cholesterol and uric acid in literature and remind their own experience with different population groups in Harar, Ethiopia, where consumption of coffee is habitual in daily life of the inhabitants.
...
PMID:[Coffee, its legend, history, and influence on human health]. 1963 81
In observational studies, high serum urate levels are associated with adverse outcomes, including mortality. However, the hypothesis that urate-lowering may improve nongout outcomes has not been confirmed by placebo-controlled clinical trials. On the contrary, 7 recent placebo-controlled trials of urate-lowering drugs with different mechanisms of action (uricosuric: lesinurad; xanthine oxidase inhibition: febuxostat; uricase: pegloticase) have observed higher mortality or trends to higher mortality in
gout
patients, with the largest decreases in serum urate. Because all urate-lowering mechanisms were implicated, this raises safety concerns about urate-lowering itself. Far from unexpected, the higher mortality associated with more intense urate-lowering is in line with the U-shaped association of urate with mortality in some observational studies. Urate accounts for most of the antioxidant capacity of plasma, and strategies to increase urate are undergoing clinical trials in
neurological disease
. Post hoc analysis of recent trials should explore whether the magnitude of urate-lowering is associated with adverse outcomes, and safety trials are needed before guidelines recommend lowering serum urate below certain thresholds.
...
PMID:Potential Dangers of Serum Urate-Lowering Therapy. 3061 33